1. Nunn, A.D.: Structure-distribution relationships of radiopharmaceuticals. Correlation between the reversed-phase capacity factors for Tc-99m phenylcarba-moylmethyliminodiacetic acids and their renal elimination. J. Chromatogr. 255: 91–100, 1983.
2. Pinkerton, T.C., Ferguson, D.L., Deutsch, E., Heineman, W.R. and Libson, K.: In vivo distributions of some component fractions of Tc(NaBH4)-HEDP mixtures separated by anion exchange high performance liquid chromatography. Int. J. Appl. Radiat. Isot. 33: 907–915, 1982.
3. Jones, A.G., Davison, A., LaTegola, M.R., Brodack, J.W., Orvig, C., Sohn, M., Toothaker, A.K., Lock, C.J.L., Franklin, K.J., Costello, C.E., Carr, S.A., Biemann, K. and Kaplan, M.L.: Chemical and in vivo studies of the anion oxo[N,N’-ethylenebis(2-mercaptoacetimido]-technetate (V). J. Nucl. Med. 23: 801–809, 1982.
4. Fritzberg, A.R., Klingensmith, W.C. III, Whitney, W.P. and Kuni, C.C.: Chemical and biological studies of Tc-99m N,N’bis(mercaptoacetamido)-ethyl-enediamine: a potential replacement for I-131 hippurate. J. Nucl. Med. 22: 258–263, 1981.
5. Fritzberg, A.R., Kuni, C.C., Klingensmith, W.C., Stevens, J. and Whitney, W.P.: Synthesis and biological evaluation of Tc-99m N,N’-bis(mercaptoacetyl)-2,3-diaminopropanoate: a potential replacement for [131I]o-iodohippurate. J. Nucl. Med. 23: 592–598, 1982.